Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Breast Cancer Risk and Progressive Histology in Serial Benign Biopsies.
Visscher DW, Frank RD, Carter JM, Vierkant RA, Winham SJ, Heinzen EP, Broderick BT, Denison LA, Allers TM, Johnson JL, Frost MH, Hartmann LC, Degnim AC, Radisky DC. Visscher DW, et al. Among authors: allers tm. J Natl Cancer Inst. 2017 Oct 1;109(10):djx035. doi: 10.1093/jnci/djx035. J Natl Cancer Inst. 2017. PMID: 28376198 Free PMC article.
Stories of breast cancer through art.
Ponto JA, Frost MH, Thompson R, Allers T, Reed-Will T, Zahasky K, Thiemann KB, Chelf JH, Johnson ME, Sterioff S, Rubin J, Hartmann LC. Ponto JA, et al. Oncol Nurs Forum. 2003 Nov-Dec;30(6):1007-13. doi: 10.1188/03.ONF.1007-1013. Oncol Nurs Forum. 2003. PMID: 14603358
Automated quantification of levels of breast terminal duct lobular (TDLU) involution using deep learning.
de Bel T, Litjens G, Ogony J, Stallings-Mann M, Carter JM, Hilton T, Radisky DC, Vierkant RA, Broderick B, Hoskin TL, Winham SJ, Frost MH, Visscher DW, Allers T, Degnim AC, Sherman ME, van der Laak JAWM. de Bel T, et al. NPJ Breast Cancer. 2022 Jan 19;8(1):13. doi: 10.1038/s41523-021-00378-7. NPJ Breast Cancer. 2022. PMID: 35046392 Free PMC article.
Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriers.
Ogony J, Hoskin TL, Stallings-Mann M, Winham S, Brahmbhatt R, Arshad MA, Kannan N, Peña A, Allers T, Brown A, Sherman ME, Visscher DW, Knutson KL, Radisky DC, Degnim AC. Ogony J, et al. Breast Cancer Res Treat. 2023 Jan;197(2):277-285. doi: 10.1007/s10549-022-06786-y. Epub 2022 Nov 16. Breast Cancer Res Treat. 2023. PMID: 36380012 Free PMC article.